Immorna Therapeutics
亦诺微医药
Immorna Therapeutics
Biotech/Healthcare
ImmVira is a developer of innovative cancer immunotherapies. The company develops, manufactures, and commercializes therapies that combine oncolytic and immune-based mechanisms, using herpesviruses to develop therapeutic cancer vaccines and provide next-generation oncolytic virus products.
Latest round: Series C Extension (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-10-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.